论文部分内容阅读
目的观察骨痛灵酊联合西药治疗风湿性关节炎的临床疗效。方法将120例风湿性关节炎患者随机分为两组。对照组采用来氟米特治疗,治疗组在对照组的基础上加敷骨痛灵酊治疗。两组患者治疗均以4周为1个疗程,共用3个疗程。结果治疗组总有效率(P<0.05);两组红细胞沉降率(ESR)、类风湿因子(RF)、C-反应蛋白(CRP)治疗后明显下降(P<0.05);治疗组ESR、RF、CRP治疗后低于对照组(P<0.05);两组治疗后握力明显高于治疗前(P<0.05),晨僵时间明显少于对照组(P<0.05);治疗组治疗后握力明显高于对照组(P<0.05),晨僵时间明显少于对照组(P<0.05);两组治疗期间无明显不良反应发生。结论骨痛灵酊联合西药治疗风湿性关节炎患者疗效显著,优势明显。
Objective To observe the clinical curative effect of Gutongling tincture and western medicine on rheumatoid arthritis. Methods 120 patients with rheumatoid arthritis were randomly divided into two groups. The control group was treated with leflunomide, and the treatment group was treated with Fugutongling tincture on the basis of the control group. Two groups of patients treated with 4 weeks for a course of treatment, sharing 3 courses. Results The total effective rate (P <0.05) in the treatment group was significantly lower than that in the control group (P <0.05). The ESR, RF and CRP decreased significantly (P <0.05). After treatment, the grip strength of CRP group was significantly higher than that before treatment (P <0.05), and the duration of morning stiffness was significantly less than that of control group (P <0.05). After treatment, the grip strength of CRP group was obviously Higher than the control group (P <0.05), morning stiffness was significantly less than the control group (P <0.05); no adverse reactions during the treatment of both groups. Conclusion Gutongling Tincture combined with Western medicine treatment of rheumatoid arthritis patients significant effect with obvious advantages.